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1. INTRODUCTION {#acel13064-sec-0001}
===============

Laminopathies are inherited degenerative disorders that are mostly related to mutations in the *LMNA* gene. This gene encodes alternative proteins, Lamin A and Lamin C, that belong to type V intermediate filaments, which are important nuclear proteins in the human body. These proteins contribute to maintaining the integrity of nuclear architecture, maintaining heterochromatin, and DNA repair (Broers, Ramaekers, Bonne, Yaou, & Hutchison, [2006](#acel13064-bib-0003){ref-type="ref"}). Hutchinson--Gilford progeria syndrome (HGPS) is one of the most severe laminopathies and a rare genetic disorder. It is typically caused by a silent mutation (c. 1824C \> T; p. Gly608Gly) in exon 11 of *LMNA* that activates an alternative pre‐mRNA cryptic splicing donor site and causes a 150‐nucleotide deletion, which results in expression of Lamin A with 50 amino acids deleted. The missing sequence of amino acids includes the recognition site for ZMPSTE24 endoprotease, which cleaves farnesylated cysteine. Thus, the mutation leads to the accumulation of a permanently farnesylated, un‐cleaved prelamin A isoform named Progerin (Gordon, Rothman, López‐Otín, & Misteli, [2014](#acel13064-bib-0013){ref-type="ref"}). Patients with HGPS begin showing premature aging features resembling normal aging before 1 year of age, including wrinkled skin, atherosclerosis, and loss of eyesight. The major cause of death for these patients is cardiovascular disease, and their average lifespan is 14.6 years (Merideth et al., [2008](#acel13064-bib-0029){ref-type="ref"}). As a result, HGPS is studied as a model for understanding the fundamental biological processes of aging diseases. Given that increased levels of reactive oxygen species (ROS) play an important role in the developing symptoms of HGPS and normal aging (Viteri, Chung, & Stadtman, [2010](#acel13064-bib-0038){ref-type="ref"}), many current studies are focusing on ameliorating oxidative stress in HGPS cells (Park & Shin, [2017](#acel13064-bib-0031){ref-type="ref"}). Indeed, oxidative stress affects a wide range of physiological and pathological functions, and excess ROS will damage various cellular components, leading to aging‐related diseases and cancers (Cui, Kong, & Zhang, [2012](#acel13064-bib-0008){ref-type="ref"}).

Notably, multiple reports have demonstrated that lysophosphatidic acid (LPA) is a potent regulator of ROS (Schmitz, Thömmes, Beier, & Vetter, [2002](#acel13064-bib-0036){ref-type="ref"}). LPA production was found to be upregulated by oxidative stress to protect microglia cells against oxidative stress‐induced cell viability through LPA receptors (Awada et al., [2012](#acel13064-bib-0002){ref-type="ref"}). LPA is a bioactive lipid mediator that is mostly synthesized from lysophosphatidylcholine (LPC) by ectoenzyme lysophospholipase D (lyso‐PLD)/autotaxin (ATX). LPA exerts multiple physiological functions through six identified G protein‐coupled receptors (GPCR), LPA~1~--LPA~6~. LPA receptor knockout (KO) mice showed that LPA has various physiologically regulatory roles, as it is involved in neuronal development (Estivill‐Torrus et al., [2008](#acel13064-bib-0011){ref-type="ref"}), angiogenesis (Chen, Chou, Chen, & Lee, [2015](#acel13064-bib-0005){ref-type="ref"}), hair follicle formation (Hayashi, Inoue, Suga, Aoki, & Shimomura, [2015](#acel13064-bib-0015){ref-type="ref"}), and hematopoiesis (Lin et al., [2016](#acel13064-bib-0026){ref-type="ref"}) through different LPA receptors. LPA modulates the levels of cAMP differently in senescent fibroblasts than in young fibroblasts. This difference in response might be attributable to the change in expression levels of each LPA receptor (Jang et al., [2006](#acel13064-bib-0018){ref-type="ref"}). In addition, LPA signaling was shown to regulate the secretion of the inflammatory signal axis IL‐6‐STAT3 (Miyabe et al., [2014](#acel13064-bib-0030){ref-type="ref"}), which is also recognized as a senescence‐associated secretory phenotype (SASP) in senescent cells (Kojima, Inoue, Kunimoto, & Nakajima, [2013](#acel13064-bib-0023){ref-type="ref"}). Moreover, our previous studies have demonstrated that the extracellular matrix (ECM) is tightly controlled by LPA signaling (Wu et al., [2008](#acel13064-bib-0041){ref-type="ref"}). At the same time, ECM dysregulation, including homeostasis imbalances of collagens, proteoglycans, and MMPs, is implicated as a critical factor in disease progression of patients with HGPS (Harten et al., [2011](#acel13064-bib-0014){ref-type="ref"}). Together, the above evidence indicates that LPA signaling might act as an important regulator for aging phenotypes of both HGPS and normal cells.

Thus, the major goal in this study is to identify the effects of LPA and LPA receptors on the aging process of HGPS cells. To investigate the relationship between LPA and HGPS, we used a Progerin‐expressing HEK293 cell model and then HGPS patient fibroblasts in this study. LPA~3~ was shown to be downregulated consistently through the lysosomal pathway in both Progerin HEK293 cells and HGPS patient fibroblasts. Moreover, activating LPA~3~ by its agonist, OMPT, abolished ROS accumulation and rescued cell senescence of Progerin cells. Notably, *Lpa~3~^−/−^* zebrafish showed multiple premature aging phenotypes. Our findings suggested that LPA regulates ROS levels and cell senescence through LPA~3~ to alleviate cell aging in HGPS.

2. RESULTS {#acel13064-sec-0002}
==========

2.1. Overexpression of Progerin alters protein levels of LPA~2~ and LPA~3~ in HEK293 cells {#acel13064-sec-0003}
------------------------------------------------------------------------------------------

To establish the HGPS cell model, wild‐type control *LMNA* cDNA and mutant *LMNA* cDNA carrying a single point mutation (c.1824 C \> T) were stably expressed in HEK293 cells (Figure [1](#acel13064-fig-0001){ref-type="fig"}a). PCR with primers designed to amplify between cryptic splicing donor sites showed a 150‐nucleotide deletion of mRNA caused by a point mutation at *LMNA* c.1824 (Figure [1](#acel13064-fig-0001){ref-type="fig"}b). Western blot analysis with Progerin (sc‐81611) and Lamin A/C (ab108595) antibodies showed that overexpression of Progerin produced truncated Lamin A protein (Figure [1](#acel13064-fig-0001){ref-type="fig"}c) and led to abnormal nucleus morphology (Figure [S1](#acel13064-sup-0001){ref-type="supplementary-material"}A). Overexpression of Progerin retarded cell proliferation and increased ROS accumulation (Figure [S1](#acel13064-sup-0001){ref-type="supplementary-material"}B‐C). In addition, overexpression of Progerin increased the percentage of senescence‐associated β‐galactosidase‐positive (SA‐β‐gal^+^) cells (Figure [S1](#acel13064-sup-0001){ref-type="supplementary-material"}D) and mRNA level of senescence‐related genes, including *p16*, *p21*, and *IL6* (Figure [S1](#acel13064-sup-0001){ref-type="supplementary-material"}E‐G). These results confirmed that overexpression of Progerin indeed caused HEK293 cell senescence.

![LPA~2~ upregulation and LPA~3~ downregulation correlate with attenuated cell proliferation and increased senescence in Progerin HEK293 cells. (a) Design of vectors expressing Lamin A and Progerin. Puromycin was applied as the selection marker to establish Progerin HEK293 stable cells. (b) PCR with primer targeting outside of the cryptic splicing site shows alternate 150‐nucleotide splicing of Lamin A mRNA in Progerin HEK293 cells. (c) Western blot with anti‐Lamin A/C (ab108595) and anti‐Progerin (sc‐81611) antibody shows expression of Progerin in Progerin HEK293 cells (d) Western blot with LPA receptor antibodies shows upregulation of LPA~2~ and downregulation of LPA~3~ in Progerin HEK293 cells. Actin was used as a loading control. (e) Cell number measurements show that, in both Lamin A and Progerin HEK293 cells, activating LPA~2~ with 5 μM of GRI decreased the cell proliferation rate, but activating LPA~3~ with 100 nM of OMPT increased the cell proliferation rate. (f) Representative images of senescence‐associated β‐gal staining assay and its quantified results. Treating Lamin A and Progerin HEK293 cells with 5 μM of GRI for 4 days increased the percentage of β‐gal‐positive cells in both cell lines. Treating Progerin HEK293 cells with 100 nM OMPT for 4 days reduced the percentage of β‐gal‐positive cells. (g) Knockdown of LPA~2~ by siRNA (siLPA~2~) reduced β‐gal‐positive Progerin HEK293 cells. Knockdown of LPA~3~ by siRNA (siLPA~3~) increased β‐gal‐positive cells. (h) Overexpression of LPA~3~ decreased β‐gal‐positive cells. (i) Real‐time qPCR showed that treatment of 100 nM OMPT for 24 hr reduced mRNA level of *p16* in Progerin HEK293 cells*.* (j) 100 nM OMPT for 24 hr reduced mRNA level of *p21.* (k) 100 nM OMPT for 24 hr reduced mRNA level of *IL6.* GAPDH was used as internal control. ANOVA and Student\'s *t* test; \**p* \< .05, \*\**p* \< .01, \*\*\**p* \< .001](ACEL-19-e13064-g001){#acel13064-fig-0001}

The Western blot analysis with LPA receptor antibodies showed that the protein level of LPA~2~ was significantly higher, whereas LPA~3~ was significantly lower in Progerin HEK293 cells than in parental HEK293 and Lamin A cells (Figure [1](#acel13064-fig-0001){ref-type="fig"}d). LPA~1~, LPA~2~, and LPA~3~ all belong to the endothelial differentiation genes (EDG) protein family and are the most studied currently (Taniguchi et al., [2017](#acel13064-bib-0046){ref-type="ref"}). Therefore, we set out to identify the roles of LPA~2~ and LPA~3~ in the progression of aging in Progerin cells.

2.2. LPA~2~ and LPA~3~ have distinct functions in regulating cell senescence in Progerin HEK293 cells {#acel13064-sec-0004}
-----------------------------------------------------------------------------------------------------

The alteration of LPA~2~ and LPA~3~ protein levels indicated that these two receptors might be involved in the cell senescence process of Progerin HEK293 cells. To investigate the functions of LPA receptors in HGPS, we applied agonists, RNA interference, and overexpression vectors of LPA receptors to Lamin A and Progerin cells in the following experiments. Two LPA receptor‐selective agonists were applied to Lamin A and Progerin HEK293 cells: LPA~2~ agonist, GRI 977143 (GRI), and LPA~3~ agonist, 2S‐OMPT (OMPT). We have used both of these common agonists in our previous research (Lin et al., [2016](#acel13064-bib-0026){ref-type="ref"}).

Treatment with 5 μM of GRI retarded cell proliferation in both Lamin A and Progerin HEK293 cells. In contrast, treatment with 100 nM of OMPT enhanced cell proliferation in both Lamin A and Progerin HEK293 cells (Figure [1](#acel13064-fig-0001){ref-type="fig"}e). Moreover, 4 days treatment with 5 μM of GRI induced higher SA‐β‐gal^+^ signals in both Lamin A and Progerin HEK293 cells, whereas 4 days treatment with 100 nM of OMPT reduced SA‐β‐gal^+^ signals in Progerin HEK293 cells (Figure [1](#acel13064-fig-0001){ref-type="fig"}f). We then knocked down LPA~2~ and LPA~3~ by siRNA in Progerin HEK293 cells to confirm the effects of LPAR agonists on cell senescence. Efficiency of siRNA is shown in Figure [S2](#acel13064-sup-0001){ref-type="supplementary-material"}A. Knockdown of LPA~2~ reduced SA‐β‐gal^+^ signals, whereas knockdown of LPA~3~ increased SA‐β‐gal^+^ signals in Progerin HEK293 cells (Figure [1](#acel13064-fig-0001){ref-type="fig"}g). Furthermore, overexpression of LPA~3~ (Figure [S2](#acel13064-sup-0001){ref-type="supplementary-material"}D) reduced SA‐β‐gal^+^ signals in Progerin HEK293 cells (Figure [1](#acel13064-fig-0001){ref-type="fig"}h). Furthermore, treatment of 100 nM OMPT to activate LPA~3~ for 1 day also reduced mRNA level of senescence‐related genes *p16*, *p21*, and *IL6* (Figure [1](#acel13064-fig-0001){ref-type="fig"}i--k). Immunostaining probing Lamin A/C showed that misshapen nuclei of Progerin HEK293 cells were ameliorated by 4 days treatment of OMPT. However, treatment of OMPT had no effects on recovery of Lamin B1 protein level, which is reduced by Progerin (Figure [S3](#acel13064-sup-0001){ref-type="supplementary-material"}). Inhibition of LPA~1~ by 100 nM of LPA~1~ antagonist AM966 for 4 days had no effect on Progerin cell senescence (Figure [S4](#acel13064-sup-0001){ref-type="supplementary-material"}A). The results above indicate that LPA~2~ and LPA~3~ oppositely regulate cell senescence in Progerin HEK293 cells.\>

2.3. LPA~2~ and LPA~3~ have distinct functions in regulating ROS in Progerin HEK293 cells {#acel13064-sec-0005}
-----------------------------------------------------------------------------------------

Given that oxidative stress is one of the representative characteristics of Progerin cells and senescent cells, we set out to investigate the effects of LPA receptors on ROS in Progerin HEK293 cells. Activating LPA~2~ by 5 μM of GRI for 24 hr enhanced ROS accumulation in both Lamin A and Progerin cells (Figure [2](#acel13064-fig-0002){ref-type="fig"}a). By contrast, activating LPA~3~ by 100 nM of OMPT reduced ROS levels in both Lamin A and Progerin cells at 24 hr (Figure [2](#acel13064-fig-0002){ref-type="fig"}b). Similarly, knockdown of LPA~2~ and LPA~3~ by shRNA showed opposite effects on ROS production: LPA~2~ enhanced ROS levels, whereas LPA~3~ reduced them in Progerin HEK293 cells (Figure [2](#acel13064-fig-0002){ref-type="fig"}c). Western blot analysis with LPAR antibodies showed reasonable knockdown efficiency of shLPA~2~ and shLPA~3~ (Sup 2B, C). In addition, overexpression of LPA~3~ reduced ROS levels in Progerin HEK293 cells (Figure [2](#acel13064-fig-0002){ref-type="fig"}d). To understand how these two receptors regulate ROS levels, we collected protein lysates from Progerin cells after treating them with 5 μM of GRI and 100 nM of OMPT for 48 hr. Western blot results showed that activating LPA~3~, but not LPA~2~, upregulated protein levels of Nrf2, SOD2, Gpx1, and NQO1, which are essential ROS‐eliminating enzymes, in Progerin cells (Figure [2](#acel13064-fig-0002){ref-type="fig"}e).

![LPA~2~ increases, but LPA~3~ suppresses ROS buildup in Progerin HEK293 cells. (a) By flow cytometry, CM‐DCFDA staining results show that activating LPA~2~ by 5 μM GRI for 24 hr increased ROS levels in both Lamin A and Progerin HEK293 cells. (b) Activating LPA~3~ by 100 nM OMPT for 24 hr decreased ROS levels in both Lamin A and Progerin HEK293 cells (c) Knockdown of LPA~2~ by shRNA (shLPA~2~) reduced ROS levels, but knockdown of LPA~3~ by shRNA (shLPA~3~) increased ROS levels in Progerin HEK293 cells. (d) Overexpression of LPA~3~ reduced ROS levels in Progerin HEK293 cells. (e) After 48 hr of 5 μM GRI and 100 nM OMPT, Western blot results showed that activation of LPA~3~, but not LPA~2~, induced expression of the antioxidant mediators Nrf2, NQO1, SOD2, and Gpx1 in Progerin HEK293 cells. Actin was used as the loading control. ANOVA and Student\'s *t* test; \**p* \< .05, \*\*\**p* \< .001](ACEL-19-e13064-g002){#acel13064-fig-0002}

2.4. Decline of LPA~3~ causes ROS accumulation and cell senescence in HGPS patient fibroblasts {#acel13064-sec-0006}
----------------------------------------------------------------------------------------------

Since the Progerin HEK293 cell model provided preliminary evidence on the roles of the LPA‐LPA receptor axis, we obtained HGPS patient fibroblasts AG11513F (AG11) and AG03199C (AG03) to compare with the previous observations. Expression of Progerin was confirmed by Western blot probing Lamin A/C and Progerin antibodies (Figure [S5](#acel13064-sup-0001){ref-type="supplementary-material"}A). In addition to SA‐β‐gal staining, mRNA level of senescence‐related genes *p16*, *p21*, and *IL6* were measured to confirm cell senescence status of HGPS patient fibroblasts (Figure [S5](#acel13064-sup-0001){ref-type="supplementary-material"}B). Western blot analysis showed lower levels of LPA~3~ and similar levels of LPA~1~ in both HGPS patient fibroblasts compared to age‐matched normal fibroblasts (AG08470B, AG08). LPA~2~ protein levels also decreased in HGPS patient fibroblasts, which was not consistent with Progeria HEK293 cells (Figure [3](#acel13064-fig-0003){ref-type="fig"}a). Moreover, a colorimetric cell viability assay Cell Counting Kit‐8 (CCK‐8) was used to determine proliferation of control and HGPS fibroblasts. Activating LPA~3~ with 100 nM of OMPT increased cell proliferation of HGPS patient and normal fibroblasts, whereas activating LPA~2~ with 5 μM of GRI had no effect on cell proliferation (Figure [3](#acel13064-fig-0003){ref-type="fig"}b). Immunofluorescent staining of Ki67 also showed that treatment of 100 nM OMPT for 24 hr increased Ki67‐positive cell percentages, indicating activation of LPA~3~ induces cell proliferation (Figure [S6](#acel13064-sup-0001){ref-type="supplementary-material"}). In addition, 7 days of treatment with 100 nM of OMPT ameliorated cell senescence of HGPS patient fibroblasts, while treatment with 5 μM of GRI had no effects (Figure [3](#acel13064-fig-0003){ref-type="fig"}c). Furthermore, treatment of 100 nM OMPT to activate LPA~3~ in HGPS patient fibroblasts for 1 day also reduced mRNA level of senescence‐related genes *p16*, *p21*, and *IL6* (Figure [3](#acel13064-fig-0003){ref-type="fig"}d--f). Treatment of 2 mM NAC for 4 days in both Progerin HEK293 cells and HGPS patient fibroblasts showed amelioration of cell senescence caused by oxidative stress (Figure [S7](#acel13064-sup-0001){ref-type="supplementary-material"}). Furthermore, treatment with 100 nM of OMPT for 2 days reduced ROS accumulation in HGPS patient fibroblasts, but 5 μM of GRI had no effects, similar to the above experiments (Figure [3](#acel13064-fig-0003){ref-type="fig"}g, Figure [S8](#acel13064-sup-0001){ref-type="supplementary-material"}). As with Progerin HEK293 cells, activating LPA~3~ with 100 nM of OMPT for 2 days rescued expression levels of Nrf2, Gpx1, SOD2, and NQO1 (Figure [3](#acel13064-fig-0003){ref-type="fig"}h). Gpx1, SOD2, and NQO1 have been shown to be regulated at the transcriptional level by Nrf2 (Shanmugam, Narasimhan, Tamowski, Darley‐Usmar, & Rajasekaran, [2017](#acel13064-bib-0037){ref-type="ref"}). Nrf2 serves as a master regulator of cellular redox homeostasis by mediating the transcriptional activation of protective genes through the antioxidant response element (ARE) (Johnson et al., [2008](#acel13064-bib-0020){ref-type="ref"}). Notably, LPA was reported to stabilize Nrf2 to protect neuron cells in patients with Huntington\'s diseases from oxidative stress (Jang et al., [2019](#acel13064-bib-0019){ref-type="ref"}). Western blot analysis and immunofluorescent staining showed that activating LPA~3~ with OMPT rescued the protein level of Nrf2 in Progerin fibroblasts. In addition, activation of LPA~3~ also rescued nuclear translocation of Nrf2 in HGPS patient fibroblasts (Figure [3](#acel13064-fig-0003){ref-type="fig"}h, Figure [S9](#acel13064-sup-0001){ref-type="supplementary-material"}). Furthermore, treatment of Nrf2 inhibitor ML385, which binds to Neh1 domain of Nrf2 to block Nrf2 transcriptional activity, was shown to cause downregulation of antioxidants and cell senescence in AG08 cells. Moreover, ML385 also abolished effect of OMPT on rescuing antioxidants and decreasing cell senescence in HGPS patient fibroblasts (Figure [S10](#acel13064-sup-0001){ref-type="supplementary-material"}). The results provided functional link between LPA~3~ and cell senescence through Nrf2 pathway. However, treatment of OMPT had no effects on recovery of Lamin B1 protein level in HGPS patient fibroblasts (Figure [3](#acel13064-fig-0003){ref-type="fig"}h). These results demonstrated that the decline of LPA~3~ destabilizes the Nrf2--antioxidant pathway and increases oxidative stress in HGPS cells.

![LPA~3~ reduction accelerates cell senescence in HGPS patient fibroblasts. (a) Western blot results show lower LPA~2~ and LPA~3~ protein levels in HGPS patient fibroblasts (AG11 and AG03) than in normal fibroblasts (AG08). (b) CCK‐8 assay revealed that activating LPA~3~ with 100 nM OMPT for 5 and 7 days rescued cell proliferation of HGPS AG11 and AG03 fibroblasts after. However, activating LPA~2~ with 5 μM GRI had no effect on cell proliferation. (c) Representative images of senescence‐associated β‐gal staining assay and its quantified results. Treating with 100 nM OMPT for 7 days reduced the percentage of β‐gal‐positive HGPS AG03 and AG11 fibroblasts. However, activating LPA~2~ with 5 μM GRI had no effect on cell senescence. (d) Real‐time qPCR showed that treatment of 100 nM OMPT for 24 hr reduced mRNA level of *p16* in HGPS patient fibroblasts (AG11 and AG03)*.* (e) 100 nM OMPT for 24 hr reduced mRNA level of *p21.* (f) 100 nM OMPT for 24 hr reduced mRNA level of *IL6.* GAPDH was used as internal control. (g) By flow cytometry, DCFDA staining results show that activating LPA~3~ by 100 nM OMPT for 48 hr decreased ROS levels in both HGPS AG03 and AG11 fibroblasts. However, activating LPA~2~ with 5 μM GRI had no effect on ROS level. (h) Western blot results show that activating LPA~3~ by 100 nM OMPT for 48 hr stabilized Nrf2 in HGPS AG11 fibroblasts and enhanced protein levels of NQO1, SOD2, and Gpx1, but not Lamin B1. Actin was used as a loading control. ANOVA and Student\'s *t* test; \**p* \< .05, \*\**p* \< .01, \*\*\**p* \< .001](ACEL-19-e13064-g003){#acel13064-fig-0003}

2.5. LPA~3~ proteins are highly internalized and sorted to the lysosome degradation pathway in Progerin HEK293 cells {#acel13064-sec-0007}
--------------------------------------------------------------------------------------------------------------------

Although we observed downregulation of LPA~3~ protein levels in Progerin HEK293 cells, real‐time qPCR analysis showed increased levels of *Lpar3* mRNA in Progerin cells than in Lamin A cells (Figure [1](#acel13064-fig-0001){ref-type="fig"}d, Figure [S11](#acel13064-sup-0001){ref-type="supplementary-material"}A). We speculated that the downregulation of LPA~3~ occurs at the post‐translational level. First, measuring the mRNA stability of *Lpar3* showed no differences between Lamin A and Progerin cells (Figure [S11](#acel13064-sup-0001){ref-type="supplementary-material"}B). Notably, having demonstrated the constitutive internalization of GPCR over time, Alcántara‐Hernández et al. showed that these receptors will reach the lysosomal compartment for degradation (Alcántara‐Hernández, Hernández‐Méndez, Campos‐Martínez, Meizoso‐Huesca, & García‐Sáinz, [2015](#acel13064-bib-0001){ref-type="ref"}). Treatment with 20 mM of NH~4~Cl and 20 nM of Bafilomycin A1, but not with 5 μM of MG132, rescued LPA~3~ degradation in Progerin HEK293 cells (Figure [4](#acel13064-fig-0004){ref-type="fig"}a--b). Furthermore, consistent with previous results, the lysosome inhibitor NH~4~Cl, but not the proteasome inhibitor MG132, rescued protein levels of LPA~3~, but not LPA~1~ or LPA~2~, in HGPS patient fibroblasts AG11 (Figure [4](#acel13064-fig-0004){ref-type="fig"}c). Likewise, the lysosome inhibitor NH~4~Cl, but not the proteasome inhibitor MG132, rescued protein levels of LPA~3~ in HGPS patient fibroblasts AG03 (Figure [4](#acel13064-fig-0004){ref-type="fig"}e). In Progerin cells, we found that internalized LPA~3~ entered the lysosomes, which we confirmed by overlapping the immunofluorescent signals of LPA~3~ and lysosomal marker LAMP‐1 (Figure [4](#acel13064-fig-0004){ref-type="fig"}d). Next, we determined the internalization of LPA receptors of both Lamin A and Progerin HEK293 cells by an LPA receptors internalization assay (Figure [4](#acel13064-fig-0004){ref-type="fig"}f). We found that the internalization of LPA~3~, but not LPA~2~, increased in Progerin cells (Figure [4](#acel13064-fig-0004){ref-type="fig"}g--h, Figure [S13](#acel13064-sup-0001){ref-type="supplementary-material"}). This indicates that the difference in LPA~3~ protein levels between Lamin A and Progerin cells is caused by the greater internalization of LPA~3~ in Progerin cells. Together, this evidence indicates that the decline of LPA~3~ in Progerin cells is due to enhanced internalization and lysosomal degradation.

![LPA~3~ is highly internalized and sorted to the lysosome degradation pathway in Progerin cells. (a) Western blot results show that treating Progerin HEK293 cells with 5 μM of MG132 for 6 hr showed no LPA~3~ protein restoration. DMSO was used as solvent control (Ctrl). (b) Western blot results show that Progerin HEK293 cells were treated with 5 mM of NH~4~Cl or 20 nM of Bafilomycin A1 (BA‐1) for 6 hr to block LPA~3~ degradation through the lysosome pathway. ddH~2~O was used as solvent control for NH~4~Cl (Ctrl in upper panel). DMSO was used as solvent control for BA‐1 (Ctrl in lower panel). (c) Western blot results show that HGPS AG11 fibroblasts were treated with 5 mM of NH~4~Cl and 5 μM of MG132 for 6 hr. NH~4~Cl treatment rescued LPA~3~, but not LPA~1~ or LPA~2~, in HGPS AG11 fibroblasts. ddH~2~O and DMSO were both loaded to control sample as solvent control (Ctrl). (d) Counter‐immunofluorescent staining by LPA~3~ and LAMP‐1 shows that LPA~3~ localized into the lysosomes in Progerin HEK293 cells. (e) Western blot results show that NH~4~Cl treatment rescued LPA~3~ in HGPS AG03 fibroblasts. ddH~2~O and DMSO were both loaded to control as solvent control (Ctrl). (f) Scheme representing the internalization assay of LPA receptors~.~ (g) Representative images of time‐dependent LPA~3~ internalization. Internalization of LPA~3~ was higher in Progerin HEK293 cells. (h) Integrated density of intracellular fluorescence was quantified to indicate internalized LPA~3~. ANOVA and Student\'s *t* test; \*\**p* \< .01, \*\*\**p* \< .001](ACEL-19-e13064-g004){#acel13064-fig-0004}

2.6. *Lpa~3~^−/−^* zebrafish shows premature aging phenotypes {#acel13064-sec-0008}
-------------------------------------------------------------

To further investigate the roles of *Lpa~3~* in the aging progress, we took advantage of an *Lpa~3~^−/−^* zebrafish model established in our previous research (Lin et al., [2018](#acel13064-bib-0027){ref-type="ref"}). Kaplan--Meier survival analysis revealed that *Lpa~3~^−/−^* zebrafish have shorter lifespans than wild‐type zebrafish (Figure [5](#acel13064-fig-0005){ref-type="fig"}a). Accumulated oxidative stress in aging individual will lead to multiple organs impairment. For instance, high oxidative stress reduces hematopoietic stem cells (HSC) of aged individuals and disrupts homeostasis of blood components (Richardson, Yan, & Vestal, [2015](#acel13064-bib-0034){ref-type="ref"}). To elucidate the effects of LPA~3~--antioxidants axis signaling impairment on different organs, we analyzed 6‐month‐old adult male zebrafish histologically with H&E staining. The number of HSC, which locates in kidney marrows of zebrafish, was lower in *Lpa~3~^−/−^* zebrafish than in corresponding wild‐type zebrafish (Figure [5](#acel13064-fig-0005){ref-type="fig"}b). This indicates that disrupting LPA~3~ signaling impairs the supply of blood cells, which agrees with our previous study (Chiang et al., [2011](#acel13064-bib-0006){ref-type="ref"}). Moreover, similar to HSC, sperm is also susceptible to oxidative stress (Sabeti, Pourmasumi, Rahiminia, Akyash, & Talebi, [2016](#acel13064-bib-0035){ref-type="ref"}). The testis of *Lpa~3~^−/−^* zebrafish showed reduced sperm production (Figure [5](#acel13064-fig-0005){ref-type="fig"}c), consistent to age‐dependent loss of sperm in LPA~3~ knockout male mice (Ye, Skinner, Kennedy, & Chun, [2008](#acel13064-bib-0044){ref-type="ref"}). Besides, bile duct hyperplasia was reported as liver damage phenotype when animal exposed to oxidative stress (Eldridge et al., [2014](#acel13064-bib-0010){ref-type="ref"}). Interestingly, bile duct hyperplasia was also observed in *Lpa~3~^−/−^* zebrafish (Figure [5](#acel13064-fig-0005){ref-type="fig"}d). Furthermore, pancreatic *β* cells are vulnerable to oxidative stress due to its high endogenous ROS level and low expression of antioxidant enzymes (Wang & Wang, [2017](#acel13064-bib-0039){ref-type="ref"}). Therefore, high accumulation of oxidative stress will lead to abnormally pancreatic islets hyperplasia, which is also observed in the *Lpa~3~^−/−^* zebrafish (Figure [5](#acel13064-fig-0005){ref-type="fig"}e). Moreover, five dpf (days postfertilization) *Lpa~3~^−/−^* zebrafish larvae showed a higher intensity of SA‐β‐gal staining than wild‐type (Figure [5](#acel13064-fig-0005){ref-type="fig"}f). Moreover, 5 dpf *Lpa~3~^−/−^* zebrafish larvae showed lower mobility after vibration induction than WT (Figure [5](#acel13064-fig-0005){ref-type="fig"}g). Furthermore, CM‐DCFDA staining results revealed that ROS level in 5 dpf *Lpa~3~^−/−^* zebrafish larvae is higher than WT (Figure [5](#acel13064-fig-0005){ref-type="fig"}h). Moreover, mRNA level of antioxidant enzyme genes, including *Gpx1a*, *SOD2*, and *NQO1*, was significantly lower in 5 dpf *Lpa~3~^−/−^* zebrafish larvae. In addition, mRNA level of *p16* and *p21* was also higher in 5 dpf *Lpa~3~^−/−^* zebrafish larvae (Figure [5](#acel13064-fig-0005){ref-type="fig"}i). These data from *Lpa~3~^−/−^* zebrafish models provide further in vivo evidence for the role of LPA~3~ decline as a driving signal for misregulation of oxidative stress aging processes globally.

![LPA~3~ deficiency in zebrafish leads to premature aging phenotypes. (a) Kaplan--Meier survival analysis demonstrated a shorter lifespan in *Lpa~3~^−/−^* zebrafish than in corresponding WT siblings (*p* value = .011, *N* \> 8). (b) Histological analysis shows hematopoietic stem cells loss in kidney marrow of 6‐month‐old *Lpa~3~^−/−^* zebrafish. (c) Sperm loss in the testis. (d) Bile duct hyperplasia. (e) Islet hyperplasia in the pancreas. (f) By senescence‐associated β‐gal staining assay, *Lpa~3~^−/−^* larvae show a positive β‐gal signal. (g) Representative images of zebrafish swimming tracks obtained and analyzed by locomotor. Locomotor results show that *Lpa~3~^−/−^* larvae had lower mobility than WT upon drastic light onset and offset. (h) CM‐DCFDA staining showed increased ROS levels in 5 dpf *Lpa~3~^−/−^* larvae. (i) Real‐time qPCR showed enhanced *p16* and p21, whereas reduced *Gpx1a*, *SOD2*, and *NQO1* of 5 dpf *Lpa~3~^−/−^* larvae. β‐Actin was used as internal control. ANOVA and Student\'s *t* test; \**p* \< .05, \*\*\**p* \< .001](ACEL-19-e13064-g005){#acel13064-fig-0005}

2.7. Knockdown of LPA~3~ sensitizes normal fibroblasts to oxidative stress {#acel13064-sec-0009}
--------------------------------------------------------------------------

Since *Lpa~3~^−/−^* zebrafish showed premature aging phenotypes, we performed siRNA knockdown of LPA~3~ in normal human skin fibroblasts (HSF) to emphasize the correlation between aging progress and LPA~3~ decline. Each LPA receptor was knocked down by siRNA and shown by Western blot (Figure [S2](#acel13064-sup-0001){ref-type="supplementary-material"}a). SA‐β‐gal staining showed that normal HSF is resistant to 10 and 50 μM of H~2~O~2~, whereas not to 100, 200, and 400 μM of H~2~O~2~ (Figure [S14](#acel13064-sup-0001){ref-type="supplementary-material"}). Cell proliferation was measured by a colorimetric cell viability CCK‐8 assay. Although knockdown of LPA~1‐3~ alone had no effect on cell proliferation (Figure [6](#acel13064-fig-0006){ref-type="fig"}a), LPA~3~ knockdown HSF showed decreased cell proliferation when exposed to 10 and 50 μM of H~2~O~2~ for 3 days that were tolerable for control, LPA~1~ and LPA~2~ knockdown HSF (Figure [6](#acel13064-fig-0006){ref-type="fig"}b). In addition, LPA~3~ knockdown fibroblasts showed higher percentages of β‐gal^+^ cells under 10 and 50 μM H~2~O~2~ treatment (Figure [6](#acel13064-fig-0006){ref-type="fig"}c, d). In normal HSF, Western blot showed that Nrf2 and antioxidant enzyme gene axis were increased to response to 100 μM of H~2~O~2~ treatment for 6 hr. However, LPA~3~ knockdown HSF failed to upregulate Nrf2 and antioxidant enzyme gene axis with 100 μM of H~2~O~2~ treatment (Figure [6](#acel13064-fig-0006){ref-type="fig"}e). Taken together, the results showed that attenuation of LPA~3~ activity will compromise cellular resistance to oxidative stress and accelerate cell senescence. This is consistent with observations from HGPS cells that LPA~3~, but not LPA~1~ or LPA~2~, is essential to resisting cell senescence caused by oxidative stress.

![LPA~3~ protects fibroblasts against cell senescence caused by oxidative stress. (a) CCK‐8 assay showed that knockdown of LPA receptors alone had no effect on cell proliferation. (b) CCK‐8 revealed that treatment with 10 μM and 50 μM H~2~O~2~ for 3 days significantly decreased cell proliferation in knockdown of LPA~3~, but not of LPA~1~ or LPA~2~. CCK‐8 reads were normalized to a sham group. (c) Representative images of senescence‐associated β‐gal staining assay. Treatment with 10 μM and 50 μM H~2~O~2~ for 3 days significantly increased percentages of β‐gal + cells in knockdown of LPA~3~, but not of LPA~1~ or LPA~2~. Quantification was shown in (d). (e) Western blot showed that 100 μM of H~2~O~2~ treatment for 6 hr increased protein level of Nrf2, NQO1, SOD2, and Gpx1, whereas LPA~3~ knockdown abolished the effects. (f) Graphical abstract of this study. ANOVA and Student\'s *t* test; \**p* \< .05, \*\**p* \< .01, \*\*\**p* \< .001](ACEL-19-e13064-g006){#acel13064-fig-0006}

3. DISCUSSION {#acel13064-sec-0010}
=============

In this study, we found that LPA~3~ diminished ROS levels by upregulating antioxidant enzymes and consequently rescued cell senescence of Progerin cells (Figure [6](#acel13064-fig-0006){ref-type="fig"}f). First, we established Progerin HEK293 cells, showing that the protein level of LPA~2~ increased, while LPA~3~ decreased. Furthermore, by cell proliferation and senescence‐associated β‐galactosidase staining, we showed that LPA~2~ and LPA~3~ oppositely regulated cell senescence of Progerin HEK293 cells. DCFDA staining showed that activating LPA~2~ increased ROS levels, but activating LPA~3~ decreased ROS levels in Progerin HEK293 cells by upregulating the ROS scavenger genes *Nrf2*, *NQO1*, *SOD2,* and *Gpx1*. We hypothesized that LPA~2~ increases ROS levels to accelerate the aging progress of Progerin HEK293 cells, while LPA~3~ ameliorates it. Accordingly, when we tested our preliminary results in HGPS patient fibroblasts, only LPA~3~ activation rescued senescent phenotypes. LPA~2~ was not upregulated in HGPS patient fibroblasts. Also, LPA~2~ had no effect on ROS accumulation and cell senescence in HGPS patient fibroblasts. Similarly, *Lpa~3~^−/−^* zebrafish showed premature aging phenotypes, which emphasize the role of LPA~3~ in protecting against the cell aging process. Next, knockdown of LPA~3~ by siRNA in normal skin fibroblasts showed that LPA~3~ is indeed essential for preventing cell aging by providing resistance against oxidative stress. Notably, the decline of LPA~3~ in Progerin HEK293cells was demonstrated to be highly internalized and sorted to the lysosomal degradation pathway. To sum up, we identified the reduction of LPA~3~ signaling as a driver for oxidative stress and aging in both HGPS cell and zebrafish models. Also, LPA~3~ agonists were shown to improve effects against oxidative stress and cell senescence in HGPS cell models.

Some previous studies have suggested the correlation between aging phenotypes and LPA signaling. For instance, significantly higher concentrations of LPA were detected in the cerebral cortex synaptosomes of aged rats (Pasquare, Gaveglio, & Giusto, [2009](#acel13064-bib-0032){ref-type="ref"}). Also, the LPA‐LPA1 axis was determined to regulate depression in elderly populations (Moreno‐Fernandez et al., [2018](#acel13064-bib-0009){ref-type="ref"}). Moreover, suppressing LPA~2~ in a mouse neuron cell line alleviated heat‐induced cell apoptosis (Kortlever, Brummelkamp, Meeteren, Moolenaar, & Bernards, [2008](#acel13064-bib-0024){ref-type="ref"}). Furthermore, LPA was shown to modulate cAMP levels in senescent fibroblasts differently than in young fibroblasts (Jang et al., [2006](#acel13064-bib-0018){ref-type="ref"}). In line with our observations, knockdown of LPA~3~ led to cell senescence in mesenchymal stromal cells (MSC) (Kanehira et al., [2017](#acel13064-bib-0021){ref-type="ref"}). Taken together, these studies and our results support the idea that LPA signaling is a potent signaling pathway with wide‐ranging effects on the aging process.

Notably, LPA‐LPAR signaling is also influential in tumor progression. Our previous studies illustrated that LPA reduces autophagy caused by nutrient depletion (Chang, Liao, Huang, & Lee, [2007](#acel13064-bib-0004){ref-type="ref"}) and activates LPA~3~ to increase VEGF‐A and VEGF‐C for tumoral lymphangiogenesis in prostate cancer. In addition, multiple groups have shown that LPA mediates epithelial--mesenchymal transition to stimulate breast cancer cell invasion and metastasis (Cho, Jeong, Park, & Lee, [2019](#acel13064-bib-0007){ref-type="ref"}). Moreover, LPA~3~ signaling has been demonstrated to be essential for the proliferation of various cell types (Zuo et al., [2018](#acel13064-bib-0045){ref-type="ref"}). Cellular replication, which is limited by cell senescence, is tightly regulated by multiple tumor suppressors and oncogenes. Bypassing cell senescence appears to be crucial for the growth and expansion of cancers (Li & Chen, [2018](#acel13064-bib-0025){ref-type="ref"}). Accordingly, we speculate that consistently reducing LPA~3~ in various senescent cell lines might prevent tumor development.

A likely scenario, based on this study and others, for how different LPA receptors contribute to LPA signaling suggests that cells might alter the expression levels of different LPA receptors under distinct cell statuses, thereby activating various downstream pathways using same ligand, LPA. For instance, the expression level of LPA~2~ is upregulated, but LPA~3~ is downregulated, during megakaryocytes lineage differentiation from chronic leukemia cell model K562 cells by phorbol 12‐myristate 13‐acetate induction (Ho et al., [2015](#acel13064-bib-0016){ref-type="ref"}). Furthermore, LPA modulates the levels of cAMP differently in senescent fibroblasts from young fibroblasts due to the change of expression levels of each LPA receptor (Jang et al., [2006](#acel13064-bib-0018){ref-type="ref"}). Together, we conclude that, in addition to altering LPA concentration, LPA receptors' expression levels are regulated to activate the signaling pathway to let cells exert distinct physiological functions, such as cell differentiation and the prevention of cell senescence.

We showed that the protein level of LPA~3~ is decreased in both Progerin HEK293 cells and HGPS patient fibroblasts due to high internalization of LPA~3~ in Progerin cells. Similarly, senescent human umbilical vein endothelial cells (HUVEC) (passages 10) also showed a reduction in LPA~3~, but not LPA~1~ nor LPA~2~ (Figure [S15](#acel13064-sup-0001){ref-type="supplementary-material"}). Although LPA~1~ and LPA~2~ both belong to the EDG protein family like LPA~3~, the protein levels of LPA~1~ and LPA~2~ are not consistently observed to be downregulated by lysosomal pathways in different senescent cells. A previous study showed that LPA~3~ is mostly phosphorylated and internalized after induction, but LPA~1~ and LPA~2~ require a longer time and a larger induction to induce internalization (Alcántara‐Hernández et al., [2015](#acel13064-bib-0001){ref-type="ref"}). It has been suggested that PDZ domains on the C‐terminal of LPA~1~ and LPA~2~ might be responsible for prolonged cell surface resident time and reduced rates of internalization (Marchese, Paing, Temple, & Trejo, [2008](#acel13064-bib-0028){ref-type="ref"}). PDZ domains are protein--protein recognition modules that bind to C‐terminal short and linear PDZ ligand sequences. Notably, δ‐opioid receptor chimera with a non‐native PDZ showed delayed internalization and prolonged protein half‐life (Puthenveedu & von Zastrow, [2006](#acel13064-bib-0033){ref-type="ref"}). However, a tyrosine‐based motif in GPCR's C‐terminal is considered to regulate the internalization of GPCR. Therefore, a tyrosine‐based motif recognized in LPA~3~'s C‐terminal might be important for regulating internalization and recycling in HGPS cells (Marchese et al., [2008](#acel13064-bib-0028){ref-type="ref"}).

Current studies mainly aim to clear Progerin to ameliorate abnormalities in nuclear shape. Farnesyltransferase inhibitors (FTI) have been reported to reverse nuclear blebbing both in vitro and in vivo (Yang, Qiao, Fong, & Young, [2008](#acel13064-bib-0043){ref-type="ref"}). Treatment with FTIs also improved body weight and survival rates of *Zmpste24^−^* ^/^ *^−^* (Fong et al., [2006](#acel13064-bib-0012){ref-type="ref"}) and HGPS‐targeted mutant mice (Yang et al., [2006](#acel13064-bib-0042){ref-type="ref"}). However, FTI‐treated mice still showed abnormal body weight curves and low amelioration of rib features. It is possible that alternative prenylation of prelamin A by geranylgeranyltransferase I after FTI treatment may lead to further limited benefits from FTIs (Whyte et al., [1997](#acel13064-bib-0040){ref-type="ref"}). Since beneficial effects of LPA~3~ on cell aging are consistent across different cell lines, identifying LPA~3~ agonists may be a high‐value health‐promoting drug discovery in the future. However, such lipid‐like ligands have problems in stability and solubility upon treatment. Most of the current available LPA‐based drug candidates are limited to lipid‐like ligands, which is understandable due to the hydrophobic environment of the LPA G protein‐coupled receptor ligand binding pockets (Kiss et al., [2012](#acel13064-bib-0022){ref-type="ref"}). Therefore, it is beneficial to develop specific nonlipid LPA~3~ agonists for potential therapeutics.

4. EXPERIMENTAL PROCEDURES {#acel13064-sec-0011}
==========================

4.1. Cell culture and pharmacological reagents {#acel13064-sec-0012}
----------------------------------------------

An HEK 293 Homo sapiens embryonic kidney cell line obtained from ATCC (Manassas, VA, USA) was maintained in Dulbecco\'s Modified Eagle\'s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (Thermo Fisher Scientific Hyclone, Waltham, MA, USA) and 1% penicillin/streptomycin. HGPS fibroblast lines AG11513F (passage 5) and AG03199C (passage 5), and age‐matched control fibroblast line AG08470B (passage 4) were received from the Coriell Institute (Camden, NJ, USA) and were maintained in minimal essential medium---Eagle\'s balance salts supplemented with 15% FBS. Normal human skin fibroblasts (HSF, passage 9) derived from neonatal foreskin were maintained in the same culture condition. All the experiments for progeria fibroblasts and HSF were performed before passage 12. Human umbilical vein endothelial cells (HUVEC) were obtained and prepared as described before (Hsia et al., [2017](#acel13064-bib-0017){ref-type="ref"}). Briefly, HUVEC harvested from human umbilical veins were plated on a culture dish and maintained in endothelial growth medium (EGM‐2 BulletKit, Lonza, Basel, Switzerland). HEK 293 and HUVEC cells were cultured at 37°C in a humidified atmosphere of 5% CO~2~. Normal human skin fibroblasts, HGPS patient fibroblasts AG11513F and AG03199C, and age‐matched control fibroblasts AG08470B were cultured under 3% oxygen in H35 HEPA Hypoxystation (Don Whitley Scientific, UK). 1‐Oleoyl‐2‐O‐methyl‐rac‐glycerophosphothionate (OMPT, Cayman Chemicals, Ann Arbor, MI, USA), GRI compound 977143 (GRI, Millipore Sigma, Burlington, MA, USA), AM966 (Cayman Chemicals), Bafilomycin A1 (Millipore Sigma), MG‐132 (Millipore Sigma), Actinomycin D (Millipore Sigma), and ML385 (Millipore Sigma) were dissolved in DMSO. Diphenyleneiodonium chloride (DPI, Millipore Sigma), N‐acetyl cysteine (NAC, Millipore Sigma), and ammonium chloride (NH~4~Cl, Millipore Sigma) were dissolved in sterile water.

4.2. Plasmid construct, RNA interference, and transfection {#acel13064-sec-0013}
----------------------------------------------------------

First, the PCR product of the LMNA gene was cloned into a pAS~2~V~1~ vector containing a puromycin‐resistant gene and amplified in E.coli (Strain: TOP10), followed by mini‐preparation (Geneaid, Taipei, Taiwan). Then, the complementary primers were used in the second PCR reaction to obtain a point mutation of the LMNA gene, Progerin. Sequences were confirmed by double‐strained sequencing (PURIGO Biotechnology, Taipei, Taiwan). Lamin A/Progerin overexpression vectors were then transfected into HEK 293 cells with Lipofectamine 2000 (Thermo Fisher Scientific) and selected by puromycin at 2 μg/ml. LPA~2~ shRNA (TRCN0000221131), LPA~3~ shRNA (TRCN0000356890), and a backbone control vector (pLKO.1‐puro) were purchased from the RNAi Core of Academia Sinica (Taipei, Taiwan) and transfected to HEK 293 cells by Lipofectamine 2000. LPA~1~, LPA~2~, and LPA~3~ siRNA were synthesized by Invitrogen (Thermo Fisher Scientific) and transfected to AG08470B cells by Lipofectamine 2000. Primer and siRNA sequences are listed in Figure [S18](#acel13064-sup-0001){ref-type="supplementary-material"}.

4.3. Western blot {#acel13064-sec-0014}
-----------------

Cells were washed with ice‐cold phosphate‐buffered saline (PBS) and scratched on ice using a lysis buffer (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 0.05% NP40, pH 7.9) with a protease inhibitor cocktail (Millipore Sigma). Lysates were incubated on ice for 15 min and then centrifuged at 4°C and 14,000 rpm for 15 min. Supernatants were collected for cytometry protein, and then, the pallets were collected for nucleus protein. For total lysates, cells were first washed with ice‐cold PBS, followed by re‐suspended in 2x Laemmli sample buffer (Bio‐Rad) containing 5% 2‐Mercaptoethanol (Millipore Sigma) with a protease inhibitor cocktail (Millipore Sigma), followed by sonication with the Digital Sonifier Cell Disruptor (Emerson, Saint Louis, MO, USA). Cycling conditions for sonication were 15 cycles of 20 s on/30 s off. Equal concentrations of samples defined by a Bradford protein assay (Bio‐Rad) were separated by 10% SDS‐polyacrylamide gel electrophoresis (PAGE) and then transferred to polyvinylidene fluoride membranes (Millipore Sigma). The membranes were blocked in TBST containing 5% nonfat dry milk, followed by incubation with specific primary antibodies diluted with TBST containing 5% bovine serum albumin (BSA, Millipore Sigma) at 4°C overnight. The membranes were then washed three times with TBST and incubated with a horseradish peroxidase‐conjugated secondary antibody at room temperature for 1 hr. Then, membranes were mixed with ECL reagents (Thermo Fisher Scientific) and imaged by X‐ray films or UVP ChemStudio Plus (Analytikjena, Jena, Germany). The band intensities were analyzed by ImageJ. Raw data for Western blot images are shown in Figures [S16](#acel13064-sup-0001){ref-type="supplementary-material"}and[S17](#acel13064-sup-0001){ref-type="supplementary-material"}. Antibodies used in this study are listed in Figure [S19](#acel13064-sup-0001){ref-type="supplementary-material"}.

4.4. Flow cytometry {#acel13064-sec-0015}
-------------------

Intracellular reactive oxygen species (ROS) were detected by flow cytometry using 2', 7'‐dichlorofluorescein diacetate (CM‐H~2~DCFDA, Millipore Sigma), a cell‐permeable dye that emits green fluorescence after redox reaction with ROS. Cells were first cultured in 6‐well plates overnight, followed by treatment with 5 μM GRI or 100 nM OMPT. Then, cells were trypsinized and re‐suspended in PBS. Cells were stained by 10 μM CM‐H~2~DCFDA for 15 min in a 37°C cell incubator and then washed in PBS. The green fluorescence signal was then detected by the green fluorescent channel using Cyflow flow cytometry (Partec, Nürnberg, Germany). For each experiment, 10 000 cells were measured and quantified.

4.5. Cell proliferation {#acel13064-sec-0016}
-----------------------

For HEK293 cell proliferation, cells were seeded in 24‐well culture plates with 1.0 × 10^4^ cells per well. After culturing overnight, the medium was replaced with medium containing LPA agonists, 5 μM GRI, or 100 nM OMPT. Cells were counted with a hemocytometer at indicated times. For HGPS patient fibroblasts, cell proliferation was evaluated by the Cell Counting Kit‐8 (CCK‐8, Dojindo Molecular Technologies, Rockville, MD, USA) according to manufacturers' instructions. Cells were first seeded in a 96‐well plate at 2.5 × 10^3^ cells per well overnight and then treated with LPA receptor agonists. After treatment with GRI or OMPT for 1--7 days, a solution of 10 μl of CCK‐8 with 90 μl of culture medium was added at the indicated time and incubated for 1 hr to develop the CCK‐8 signal. Then, the absorbance at 450 nm wavelength was determined by a Spark^®^ multimode microplate reader (TECAN, Männedorf, Switzerland).

4.6. Senescence‐associated beta‐galactosidase assay {#acel13064-sec-0017}
---------------------------------------------------

Cells were fixed with 2% formaldehyde and 0.2% glutaraldehyde in PBS. Then, the staining procedure was performed in the staining solution of X‐gal (pH = 5.9--6.1) at 37°C for at least 24 hr. After blue color was fully developed, percentage of blue SA‐β‐gal‐positive cells were counted under a microscope. To prepare the staining dye, 0.1% of X‐gal (stock: 1% in DMSO, Millipore Sigma), 5 mM potassium ferrocyanide (stock: 0.5 M, Millipore Sigma), 5 mM potassium ferricyanide (stock: 0.5 M, Millipore Sigma), 150 mM sodium chloride (NaCl, Millipore Sigma), and 2 mM magnesium chloride (MgCl~2~, Millipore Sigma) were added to 40 mM citric acid/sodium phosphate solution (stock: 400 mM, Millipore Sigma). The pH value was verified as 5.9--6.1 and adjusted by 0.1 M citric acid, if necessary. The SA‐β‐gal‐positive cells stained blue‐green color and were scored under a Zeiss AxioImager bright‐field microscopy. Results were generated from at least three independent experiments. More than 500 cells were counted in each experimental condition.

4.7. Internalization and immunofluorescent staining {#acel13064-sec-0018}
---------------------------------------------------

For the LPA~2~ and LPA~3~ internalization assays, Lamin A and Progerin HEK293 cells were first cultured on glass slides overnight. Then, LPA receptors on the cell surface were labeled by antibodies that recognize the N‐terminal of LPA receptor proteins (outside the plasma membrane) and prepared in serum‐free DMEM containing 1% BSA, for 1 hr on ice. After washing three times by serum‐free DMEM, glass slides were returned to a 37°C incubator. Glass slides were then collected at serial time points for surface antibody retrieval using an acidic medium (0.5% acetic acid, 0.5M NaCl, 0.05% BSA, pH = 4.0), followed by 2% paraformaldehyde (PFA, Millipore Sigma) fixation for 10 min and permeabilized by 0.5% Triton X (Millipore Sigma) for 5 min. Internalization assay of LPA~3~ without surface antibody retrieval was shown in Figure [S12](#acel13064-sup-0001){ref-type="supplementary-material"}. The internalized antibody was then labeled using a secondary antibody, anti‐rabbit IgG conjugated with Alexa 488. For immunofluorescent staining, Progerin HEK293 cells were cultured on glass slides overnight, then fixed by 2% PFA, and permeabilized by 0.5% Triton X for 5 min. After PBS wash, glass slides were incubated with primary antibodies for 2 hr and then labeled with fluorescent secondary antibodies for 1 hr. Fluorescent images were developed by Zeiss LSM 880 confocal microscopy. Antibodies used in this study are listed in Figure [S19](#acel13064-sup-0001){ref-type="supplementary-material"}.

4.8. Establishment and maintenance of LPA~3~ knockout Zebrafish {#acel13064-sec-0019}
---------------------------------------------------------------

Establishment of LPA~3~ knockout zebrafish was described in Figures [S1--S19](#acel13064-sup-0001){ref-type="supplementary-material"}. For genotyping, we extracted genomic DNA (gDNA) from the tail fins of 1‐month‐old zebrafish using a digesting buffer (1 mg/ml proteinase K in TE buffer). Genotyping was performed by Sanger sequencing (PURIGO Biotechnology). Primers to amplify gDNA for Sanger sequencing are as follows: F'ataactgaaaccctttagacccac; R'ccaatttagagcacagatccagac. Zebrafish used in the present study were maintained following the zebrafish caring standard in the National Taiwan University Zebrafish Core Laboratory (Taipei, Taiwan).

4.9. Histological analysis of adult zebrafish {#acel13064-sec-0020}
---------------------------------------------

Six‐month‐old adult zebrafish were sacrificed by cold 4 mg/ml of *N*‐(Tris\[hydroxymethyl\]methyl) glycine (Tricaine, Merck, Kenilworth, NJ, USA) and then immediately fixed for 1 week with Bouin solution (75% saturated picric acid, 10% formaldehyde, 5% glacial acetic acid). After fixation, zebrafish were transferred to 70% ethanol to remove excess picric acid. For paraffin embedding, zebrafish were gradually dehydrated as follows: 70% ethanol for 1 hr, 80% ethanol for 1 hr, 90% ethanol for 1 hr, and twice absolute ethanol for 1 hr. Then, zebrafish were incubated at 60°C and infiltrated as follows: first, cleared by xylene for 15 min; second, cleared by 50% xylene and 50% soft paraffin for 15 min; and finally, infiltrated by hard paraffin for 25--30 min. Lastly, zebrafish were immediately embedded in hard paraffin and then properly trimmed to cutting size. Paraffin blocks were then sectioned at 7 μm by microtome. Histological hematoxylin--eosin (H&E) staining of the sections was subsequently performed using standard protocols. Sections were mounted with Fisher Chemical^TM^ Permount^TM^ mounting medium (Thermo Fisher Scientific) and observed using an Olympus IX73 inverted microscope system.

4.10. Zebrafish larvae mobility {#acel13064-sec-0021}
-------------------------------

Zebrafish larvae were kept in groups at 26--28°C in a light:dark rhythm of 14:10 hr. Each treatment group of 4 days postfertilization (dpf) zebrafish larvae was transferred into an individual well of 24‐well plates before the experiments. To detect alterations in the mobility of zebrafish larvae between different genotypes, we used the DanioVision^TM^ observation system (Noldus, Wageningen, Netherlands) to monitor and analyze the swimming tracks of zebrafish larvae. A discrete tap at the bottom of the plate holder creates a vibration in the water that evokes a startle response from the zebrafish larvae. The zebrafish larvae\'s tracks were recorded continually for 1 min after tap stimulation, and the swimming distances were summed every 10 s for quantification.

4.11. Reverse transcription (RT) and real‐time qPCR {#acel13064-sec-0022}
---------------------------------------------------

RNA was extracted from cells using TRIZOL (Thermo Fisher Scientific Invitrogen). Complementary DNA was synthesized with 1 µg total RNA using Toyobo RT‐PCR kit. (Toyobo, Osaka, Japan). The iCycler iQ real‐time detection system (Bio‐Rad, Hercules, CA, USA) with SYBR‐Green I (Bio‐Rad) was used to perform real‐time qPCR. Gene‐specific primers were used, and specificity for the primers was checked by melting curve analysis. Cycling conditions were 95°C for 3 min, followed by 40 cycles of 95°C for 30 s, and 60°C for 30 s. To quantify the target gene expression, each gene was normalized using GAPDH as internal control. Primer sequences are listed in Figure [S18](#acel13064-sup-0001){ref-type="supplementary-material"}.

4.12. Determination of mRNA stability {#acel13064-sec-0023}
-------------------------------------

10^5^ Lamin A and Progerin HEK293 cells were first cultured in 6‐well plates overnight, followed by 5 μg/ml Actinomycin D. Cell lysates were then collected at indicated times by TRIZOL. Total RNA was reverse transcribed to complementary DNA, and LPA~3~ mRNA decline was determined by real‐time qPCR. Primer sequences are listed in Figure [S18](#acel13064-sup-0001){ref-type="supplementary-material"}.

4.13. Statistical analysis {#acel13064-sec-0024}
--------------------------

Data were analyzed by one‐way analysis of variance (ANOVA) and Fisher\'s protected least significant difference (LSD) tests (Stat‐View, Abacus Concept, Berkeley, CA, USA). Each result was obtained after three to six independent experiments, and a *p* value of \<.05 was considered statistically significant.
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